Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.

By T. Maurer, J. Gschwend, I. Rauscher, M. Souvatzoglou, B. Haller, G. Weirich, H. Wester, M. Heck, H. Kübler, A. Beer and 2 more. Journal of Urology, 2016

706 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/a5c9bd48f8b5fd47f879767d6bddc961f4eaccd3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. W. Fendler
2. M. Eiber
3. M. Beheshti
4. J. Bomanji
5. U. Haberkorn
6. F. Ceci
7. H. Wester
8. F. Giesel

Citations in the corpus

• 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 (2017, background): “of all prostate cancers do not exhibit significant PSMA overexpression [22, 44].”